Fifth Third Bancorp »

Amylyx Pharmaceuticals shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $11k 755 13.90

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Amylyx Pharmaceuticals

FMR
BlackRock
Perceptive Advisors
TCG Crossover Management
Commodore Capital
Henderson Group
Saturn V Capital Management
Vanguard Capital Management
Adage Capital Partners GP
First Light Asset Management
Driehaus Capital Management
Goldman Sachs Group
State Street Corporation
Franklin Resources
Geode Capital Management

View all funds holding Amylyx Pharmaceuticals